Belgium doctors treating critically ill infants favour legalising euthanasia
Main Category: Pediatrics / Children's HealthAlso Included In: Palliative Care / Hospice Care
Article Date: 08 Apr 2005 - 11:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
1 (1 votes) |
Most paediatricians in Flanders, Belgium, favour the legalisation of lethal drugs to end the life of some critically ill babies and infants, concludes a study in this week's issue of The Lancet.
Doctors are increasingly confronted with end-of-life decisions in critically ill babies and infants. Little is known about the frequency of end-of-life decisions in this population, the clinical and demographic characteristics of these patients, and the attitudes of doctors who care for these patients.
Luc Deliens (Vrije Universiteit Brussel, Belgium) and colleagues looked at the death certificates for all neonates and infants in the whole of Flanders who died between August 1999 and July 2000. 292 children were born alive and died in Flanders within the first year of life over this period. 175 doctors in charge of these cases were identified and sent anonymous questionnaires. 121 of the 175 doctors involved completed the attitude questions.
An end-of-life decision was made in 143 cases (57%). End-of-life decisions include withdrawing or withholding treatment, using drugs to alleviate pain that could potentially shorten life, or using drugs with the explicit intention of shortening the patient's life.
The use of lethal drugs in minors is illegal in Belgium. However, the study found that lethal doses or lethal drugs were administered in 17 cases (9%). 95 (79%) of the 121 doctors thought that their professional duty sometimes includes the prevention of unnecessary suffering by hastening death and 69 (58%) of 120 supported legalisation of termination in some cases.
Professor Deliens states: "We found that about three in four physicians who are confronted with critically ill neonates and infants are willing to participate in certain forms of life termination in these children. The main reasons for shortening of the neonate's life were the absence of real survival chances, and, if the baby survived, an expected very poor quality of life."
Also in this week's issue of The Lancet a Research Letter by Astrid Vrakking (University Medical Centre Rotterdam, Netherlands) and colleagues finds that the frequency of the active ending of life of infants has not risen in the Netherlands despite its new, more liberal, regulatory system of such actions.
In an accompanying Comment Chris Feudtner (Children's Hospital of Philadelphia, USA) outlines five issues in the euthanasia debate. He states: "If we want a policy that would reduce acts of killing to a minimum, we need far better evidence from various practice settings about the impact of end-of-life-care policies on actual clinical practice."
http://www.thelancet.com
Visit our pediatrics / children's health section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/22532.php>
APA
http://www.medicalnewstoday.com/releases/22532.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





